Erratum: First evidence of intra-familial transmission of an HIV-1 M/O intergroup recombinant virus (AIDS (2016) 30 (1-8) DOI: 10.1097/QAD.0000000000000880);First evidence of transmission of an HIV-1 M/O intergroup recombinant virus

AIDS

Volumn 30, Issue 1, 2016, Pages 1-8

  Ngoupo, Paul Alain ^a,c,d   Sadeuh Mba, Serge Alain ^a   De Oliveira, Fabienne ^d   Ngono, Valérie ^a   Ngono, Laure ^a   Tchendjou, Patrice ^b   Penlap, Véronique ^c   Mourez, Thomas ^d   Njouom, Richard ^a   Kfutwah, Anfumbom ^a   Plantier, Jean Christophe ^d  

^a Service de Virologie   (Cameroon)

^b CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

breakpoints; direct transmission; HIV 1 M O recombinant

Indexed keywords

LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; ZIDOVUDINE; VIRUS ENVELOPE PROTEIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CAMEROON; CASE REPORT; ENVELOPE GENE; FEMALE; GENE SEQUENCE; GENETIC DISTANCE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP M; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP O; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPING; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS TRANSMISSION; CLASSIFICATION; DNA SEQUENCE; GENETIC RECOMBINATION; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PHYLOGENY; SEROTYPE; SPOUSE; TRANSMISSION; VIROLOGY;

ADULT; CAMEROON; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; GENOME, VIRAL; GENOTYPE; GENOTYPING TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SEROGROUP; SEROTYPING; SPOUSES;

EID: 84957672560     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000511469.20428.82     Document Type: Erratum

References (30)

1. Plantier J-C, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemée V, et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009; 15:871-872.
2. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, et al. HIV-1 nomenclature proposal. Science 2000; 288:55-56.
3. Vallari A, Holzmayer V, Harris B, Yamaguchi J, Ngansop C, Makamche F, et al. Confirmation of putative HIV-1 group P in Cameroon. J Virol 2011; 85:1403-1407.
4. Ayouba A, Akoua-Koffi C, Calvignac-Spencer S, Esteban A, Locatelli S, Li H, et al. Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Cote d'Ivoire. AIDS 2013; 27:2488-2491.
5. Yamaguchi J, Bodelle P, Vallari AS, Coffey R, McArthur CP, Schochetman G, et al. HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. AIDS Res Hum Retroviruses 2004; 20:944-957.
6. Vergne L, Bourgeois A, Mpoudi-Ngole E, Mougnutou R, Mbuagbaw J, Liegeois F, et al. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02-AG variant and disease stage. Virology 2003; 310:254-266.
7. Brand D, Beby-Defaux A, Mace M, Brunet S, Moreau A, Godet C, et al. First identification of HIV-1 groups M and O dual infections in Europe. AIDS 2004; 18:2425-2428.
8. Takehisa J, Zekeng L, Ido E, Yamaguchi-Kabata Y, Mboudjeka I, Harada Y, et al. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999; 73:6810-6820.
9. Peeters M, Liegeois F, Torimiro N, Bourgeois A, Mpoudi E, Vergne L, et al. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 1999; 73:7368-7375.
10. Vessiere A, Leoz M, Brodard V, Strady C, Lemee V, Depatureaux A, et al. First evidence of a HIV-1M/O recombinant form circulating outside Cameroon. AIDS 2010; 24:1079-1082.
11. Plantier JC, Djemai M, Lemee V, Reggiani A, Leoz M, Burc L, et al. Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol 2009; 47:2906-2911.
12. Henquell C, Jacomet C, Antoniotti O, Chaib A, Regagnon C, Brunet S, et al. Difficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection. J Clin Microbiol 2008; 46:2453-2456.
13. Yamaguchi J, Vallari AS, Swanson P, Bodelle P, Kaptue L, Ngansop C, et al. Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters. AIDS Res Hum Retroviruses 2002; 18:269-282.
14. Roques P, Robertson DL, Souquiere S, Damond F, Ayouba A, Farfara I, et al. Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology 2002; 302:259-273.
15. Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, et al. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol 1997; 71:8893-8898.
16. Kfutwah A, Lemee V, Ngono HV, De Oliveira F, Njouom R, Plantier JC. Field evaluation of the Abbott ARCHITECT HIV Ag/ Ab Combo immunoassay. J Clin Virol 2013; 58 (Suppl 1):e75.
17. Simon F, Souquiere S, Damond F, Kfutwah A, Makuwa M, Leroy E, et al. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retroviruses 2001; 17:937-952.
18. Vessiere A, Rousset D, Kfutwah A, Leoz M, Depatureaux A, Simon F, et al. Diagnosis and monitoring of HIV-1 group Oinfected patients in Cameroun. J Acquir Immune Defic Syndr 2010; 53:107-110.
19. Dachraoui R, Depatureaux A, Chakroun M, Fodha I, Letaief A, Trabelsi A, et al. Monitoring of HIV-1 resistance in Tunisia (North Africa) with a dried plasma spot strategy. J Acquir Immune Defic Syndr 2008; 47:522-525.
20. Plantier JC, Dachraoui R, Lemee V, Gueudin M, Borsa-Lebas F, Caron F, et al. HIV-1 resistance genotyping on dried serum spots. AIDS 2005; 19:391-397.
21. Heyndrickx L, Janssens W, Gurtler L, Zekeng L, Loussert-Ajaka I, Vereecken K, et al. Differential diagnosis of HIV type 1 groupO and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragment. AIDS Res Hum Retroviruses 1998; 14:973-977.
22. Vessiere A, De Oliveira F, Leoz M, Rousset D, Kfutwah A, Simon F, Plantier JC. HIV-1M/O dual infections and recombinant forms circulating in Cameroon and France. Poster presentation; 18th Conferences on Retroviruses and Opportunistic Infection, Boston MA, USA 2011.
23. Hu W-S, Hughes S H. HIV-1 reverse transcription. Cold Spring Harb Perspect Med 2012; 2:a006882.
24. Delviks-Frankenberry K, Galli A, Nikolaitchik O, Mens H, Pathak VK, Hu WS. Mechanisms and factors that influence high frequency retroviral recombination. Viruses 2011; 3:1650-1680.
25. Basu VP, Song M, Gao L, Rigby ST, Hanson MN, Bambara RA. Strand transfer events during HIV-1 reverse transcription. Virus Res 2008; 134:19-38.
26. Lemey P, Pybus OG, Rambaut A, Drummond AJ, Robertson DL, Roques P, et al. The molecular population genetics of HIV-1 group O. Genetics 2004; 167:1059-1068.
27. Zouhair S, Roussin-Bretagne S, Moreau A, Brunet S, Laperche S, Maniez M, et al. Group O human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays. J Clin Microbiol 2006; 44:662-665.
28. Aghokeng AF, Mpoudi-Ngole E, Dimodi H, Atem-Tambe A, Tongo M, Butel C, et al. Inaccurate diagnosis of HIV-1 groupM and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One 2009; 4:e7702.
29. Kfutwah AK, Ngono V, Ngoupo PA, Njouom R. An antiretroviral drug-naive human immunodeficiency virus-1 infected woman with a persistent nonreactive proviral deoxyribonucleic acid polymerase chain reaction: A case report. J Med Case Rep 2013; 7:152.
30. Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, et al. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr 2007; 45:380-388.